Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Cold & Cough Remedies (Pharmacies) market in Ecuador has been experiencing steady growth in recent years.
Customer preferences: Ecuadorians place a high value on their health and well-being, making the Cold & Cough Remedies market an important segment of the pharmaceutical industry. With a growing awareness of the importance of preventive healthcare, consumers are increasingly seeking out remedies to alleviate cold and cough symptoms. They are also becoming more proactive in managing their health, leading to increased demand for over-the-counter remedies that can be easily purchased at pharmacies.
Trends in the market: One of the key trends in the Cold & Cough Remedies market in Ecuador is the shift towards natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic medications and are turning to natural alternatives. This trend is reflected in the increasing availability of herbal remedies in pharmacies across the country. Manufacturers are also responding to this demand by developing and marketing natural cold and cough remedies. Another trend in the market is the rising popularity of combination remedies. Consumers are looking for products that provide relief for multiple symptoms, such as congestion, cough, and sore throat, in a single dose. Combination remedies offer convenience and cost savings for consumers, which has contributed to their growing popularity.
Local special circumstances: Ecuador has a diverse climate and geography, which can contribute to the prevalence of cold and cough symptoms. The country is located on the equator, resulting in a tropical climate in coastal areas and a more temperate climate in the highlands. These varying climates can lead to changes in temperature and humidity, which can increase the risk of colds and respiratory infections. Additionally, Ecuador is known for its high levels of air pollution in urban areas, which can also contribute to respiratory issues.
Underlying macroeconomic factors: Ecuador has been experiencing steady economic growth in recent years, which has led to an increase in disposable income. This has allowed consumers to spend more on healthcare products, including cold and cough remedies. Additionally, the government has been investing in improving the healthcare infrastructure in the country, which has increased access to pharmacies and healthcare services. These factors have contributed to the growth of the Cold & Cough Remedies market in Ecuador. In conclusion, the Cold & Cough Remedies market in Ecuador is growing due to customer preferences for natural and combination remedies, as well as the country's diverse climate and improving healthcare infrastructure. The underlying macroeconomic factors, such as steady economic growth and increased disposable income, have also contributed to the market's development.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.